ZA892907B - Peptides derived from human immunodeficiency virus-1 gp160 - Google Patents

Peptides derived from human immunodeficiency virus-1 gp160

Info

Publication number
ZA892907B
ZA892907B ZA892907A ZA892907A ZA892907B ZA 892907 B ZA892907 B ZA 892907B ZA 892907 A ZA892907 A ZA 892907A ZA 892907 A ZA892907 A ZA 892907A ZA 892907 B ZA892907 B ZA 892907B
Authority
ZA
South Africa
Prior art keywords
immunodeficiency virus
human immunodeficiency
peptides derived
peptides
derived
Prior art date
Application number
ZA892907A
Inventor
Mark I Greene
I Greene Mark
William Williams
Williams William
David Weiner
Weiner David
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of ZA892907B publication Critical patent/ZA892907B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA892907A 1988-04-20 1989-04-20 Peptides derived from human immunodeficiency virus-1 gp160 ZA892907B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18384088A 1988-04-20 1988-04-20

Publications (1)

Publication Number Publication Date
ZA892907B true ZA892907B (en) 1990-03-28

Family

ID=22674513

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA892907A ZA892907B (en) 1988-04-20 1989-04-20 Peptides derived from human immunodeficiency virus-1 gp160

Country Status (7)

Country Link
KR (1) KR900700626A (en)
AU (1) AU3557889A (en)
CA (1) CA1341391C (en)
IE (1) IE61966B1 (en)
PT (1) PT90329B (en)
WO (1) WO1989010416A1 (en)
ZA (1) ZA892907B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346989A (en) * 1990-08-22 1994-09-13 Syntello Vaccine Development Kb Peptides for use in induction of T cell activation against HIV-1
EP0550599B1 (en) * 1990-09-27 2003-04-23 Tripep AB Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
US5840313A (en) * 1990-09-27 1998-11-24 Syntello Vaccine Development Kb Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
EP0594638A1 (en) * 1991-06-03 1994-05-04 Syntello Vaccine Development Ab Peptides for use in induction of t cell activation against hiv-1
FR2677364A1 (en) * 1991-06-05 1992-12-11 Pasteur Institut Peptide sequences of the external HIV-1 retrovirus envelope glycoprotein
GB9208428D0 (en) * 1992-04-16 1992-06-03 Proteus Molecular Design Synthetic polypeptides
DE4405810A1 (en) 1994-02-23 1995-08-24 Behringwerke Ag Peptides derived from a retrovirus from the HIV group and their use
GB2313376A (en) * 1996-05-22 1997-11-26 Diapharm Limited Polypeptide immunologically cross-reactive with NTM peptide and with vasoactive intestinal peptide (VIP)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743678A (en) * 1983-04-27 1988-05-10 President And Fellows Of Harvard College Method and products for detection of human T cell leukemia virus

Also Published As

Publication number Publication date
IE61966B1 (en) 1994-11-30
WO1989010416A1 (en) 1989-11-02
PT90329A (en) 1989-11-10
PT90329B (en) 1994-09-30
KR900700626A (en) 1990-08-16
IE891260L (en) 1989-10-20
CA1341391C (en) 2002-10-01
AU3557889A (en) 1989-11-24

Similar Documents

Publication Publication Date Title
NZ220653A (en) Hiv env region peptides and d-retro versions thereof
ZA924150B (en) Vaccine for human immunodeficiency virus
IL93927A0 (en) Replication competent human immunodeficiency type 2 proviral clone
EP0853662A4 (en) Novel replication competent human immunodeficiency virus type 2 (hiv-2) proviral clone designated hiv-2kr
ZA892907B (en) Peptides derived from human immunodeficiency virus-1 gp160
ZA878336B (en) Peptides
AU3836489A (en) Treatment of immunodeficiency
GB8807427D0 (en) Peptides
GB8629116D0 (en) Env/gag polypeptides
EP0327334A3 (en) Phospholipase a2-inhibiting peptides
ZA883878B (en) Human immunodeficiency virus gag-encoded proteins
GB8619182D0 (en) Peptides & derivatives
IL90833A0 (en) Immunogenic peptide
GB8828097D0 (en) Peptides
ZA935165B (en) Developments relating to human immunodeficiency viruses
ZA878945B (en) Peptides
ZA873796B (en) Peptides
IE881635L (en) Human immunodeficiency virus gag-encoded proteins
GB8828098D0 (en) Peptides
GB2273710B (en) Peptide fragments of HIV
IE862784L (en) Vasopressin peptides
GB9111574D0 (en) Developments relating to human immunodeficiency viruses
GB8818271D0 (en) Treatment of immunodeficiency
IE883123L (en) Treatment of immunodeficiency
GB9211286D0 (en) Recombinant retroviruses